000 03019nam a22003855i 4500
999 _c75900
_d75900
_x1
001 75900
003 ES-MaUEC
005 20230207040202.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 121206s2013 xxu| s |||| 0|eng d
020 _a9781461452607
024 7 _a10.1007/978-1-4614-5260-7
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280.B6
_bA382 2013 EB
245 0 0 _aAdvances in Biology and Therapy of Multiple Myeloma
_nVolume 2,
_pTranslational and Clinical Research
_cedited by Nikhil C. Munshi, Kenneth C. Anderson
260 _aNew York
_bSpringer International Publishing
_c2013
300 _a1 recurso en línea (X, 287 p.)
_b7 ilustraciones, 5 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aT cell responses in myeloma -- Novel antigenic targets for immunotherapy in myeloma -- Antibody-based therapies in Multiple Myeloma -- Defining multiple myeloma as a target for DNA gene fusion vaccines -- Harnessing allogeneic immunity for anti-myeloma response -- Dendritic cell and peptide-based vaccination in myeloma -- New Proteasome inhibitors -- Newer Imids -- New agents in myeloma -- Early Combination Studies in MM -- The effect of novel antimyeloma agents on bone metabolism -- Index.
520 3 _aDespite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact.
988 _aEBOOK, EBSPRINGERrevisado
650 7 _aHuesos
_xTumores
_9182468
_0comprobar BNE19901362136
_2embne
650 7 _aMieloma múltiple
_0comprobar BNE20021387571
_2embne
_9160182
700 1 _aAnderson, Kenneth C
_eeditor literario
_946459
700 1 _aMunshi, Nikhil C.
_eeditor literario
_984566
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4614-5260-7
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12815184
_b10-10-17
_c01-10-14
942 _2lcc
_cLE
945 _aRC280 .B6 A382 2013 EB
_cV. 2
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11544569
_z06-04-17
998 _dz
_ea
_feng
_gxxu
_h0